Bibliography
- HARRINGTON EA, BEBBINGTON D, MOORE J et al.: VX-680, a potent and select small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat. Med. (2004) 10:262–267.
- KATAYAMA H, BRINKLEY WR, SEN S: The Aurora kinases; role in cell transformation and tumorigenesis. Cancer Metastasis Rev (2003) 22:451–464.
- GEORGE P, BALI P, COHEN P et al: Cotreatment with 17-allkylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3. Cancer Res. (2004) 64:3645–3652.
- HAUF S, COLE RW, LATERRA S et al: The small molecule Hesparadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoints. J. Cell Biol. (2003) 161:281–294.
- DITCHFIELD C, JOHNSON VL, TIGHE A et al.: Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J. Cell Biol. (2003) 161:267–280.